The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials

5Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Background: Several cluster-randomized HIV prevention trials aim to demonstrate the population-level preventive impact of antiretroviral therapy (ART). 2013 World Health Organization (WHO) guidelines raising the ART initiation threshold to CD4 <500/μL could attenuate these trials' effect size by increasing ART usage in control clusters. Methods: We used a computational model to simulate strategies from a hypothetical cluster-randomized HIV prevention trial. The primary model outcome was the relative reduction in 24-month HIV incidence between control (ART offered with CD4 below threshold) and intervention (ART offered to all) strategies. We assessed this incidence reduction using the revised (CD4 <500/μL) and prior (CD4 <350/μL) control ART initiation thresholds. Additionally, we evaluated changes to trial characteristics that could bolster the incidence reduction. Results: With a control ART initiation threshold of CD4 <350/μL, 24-month HIV incidence under control and intervention strategies was 2.46/100 person-years (PY) and 1.96/100 PY, a 21% reduction. Raising the threshold to CD4 <500/μL decreased the incidence reduction by more than one-third, to 12%. Using this higher threshold, moving to a 36-month horizon (vs 24-month), yearly control-strategy HIV screening (vs biannual), and intervention-strategy screening every 2 months (vs biannual), resulted in a 31% incidence reduction that was similar to effect size projections for ongoing trials. Alternate assumptions regarding cross-cluster contamination had the greatest influence on the incidence reduction. Conclusions: Implementing the 2013 WHO HIV treatment threshold could substantially diminish the incidence reduction in HIV population prevention trials. Alternative HIV testing frequencies and trial horizons can bolster this incidence reduction, but they could be logistically and ethically challenging. The feasibility of HIV population prevention trials should be reassessed as the implementation of treatment guidelines evolves.

References Powered by Scopus

Prevention of HIV-1 infection with early antiretroviral therapy

5744Citations
N/AReaders
Get full text

Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis

793Citations
N/AReaders
Get full text

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study

662Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Laboratory monitoring of antiretroviral therapy for HIV infection: Cost-effectiveness and budget impact of current and novel strategies

12Citations
N/AReaders
Get full text

Burden of hepatitis B virus and syphilis co-infections and its impact on HIV treatment outcome in Ethiopia: nationwide community-based study

4Citations
N/AReaders
Get full text

A systematic review and cost-effectiveness analyses of the new World Health Organization guidelines for the treatment of HIV-positive adults in India

4Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ross, E., Tanser, F., Pei, P., Newell, M. L., Losina, E., Thiebaut, R., … Walensky, R. (2014). The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials. HIV Clinical Trials, 15(5), 185–198. https://doi.org/10.1310/hct1505-185

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

45%

Researcher 12

36%

Lecturer / Post doc 4

12%

Professor / Associate Prof. 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 14

56%

Nursing and Health Professions 7

28%

Social Sciences 2

8%

Immunology and Microbiology 2

8%

Save time finding and organizing research with Mendeley

Sign up for free